SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000950133-99-000542
Filing Date
1999-02-19
Accepted
1999-02-19 00:00:00
Documents
1
Group Members
BB BIOTECH AGBIOTECH FOCUS S.A.

Document Format Files

Seq Description Document Type Size
1 SC 13G/A SC 13G/A 15249
  Complete submission text file 0000950133-99-000542.txt   17168
Mailing Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006
Business Address C/O BAKER & MCKENZIE 815 CONNECTICUT AVENUE NW WASHINGTON DC 20006 2028351882
BB BIOTECH AG (Filed by) CIK: 0000924223 (see all company filings)

State of Incorp.: DC | Fiscal Year End: 1231
SIC: 0000

Mailing Address
Business Address 275 ARMAND FRAPPIER BOULEVARD LAVAL PROVICE QUEBEC A8 00000 5146811744
CLINICHEM DEVELOPMENT INC (Subject) CIK: 0001054396 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54385 | Film No.: 99545509
SIC: 2834 Pharmaceutical Preparations